SCHEMBL7794663

SCHEMBL7794663

CC(C)(N)C(=O)N[C@@H]1CSc2cc(F)ccc2N(Cc2ccc(-c3ccccc3CNC(=O)NCCO)cc2)C1=O

nearest known ligand 0.68

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.68
DRD2 P14416 6/20 0.38
DRD4 P21917 6/20 0.38
DRD3 P35462 6/20 0.38
XIAP P98170 1/20 0.38
F7 P08709 6/20 0.36
F3 P13726 6/20 0.36
F2 P00734 3/20 0.36
AGTR1 P30556 1/20 0.35
KCNA5 P22460 1/20 0.34
KCNH2 Q12809 1/20 0.34
F10 P00742 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7785981 0.94 GHSR (0.68) GHSRDRD2DRD4DRD3XIAP
SCHEMBL7794384 0.93 GHSR (0.67) GHSRDRD2DRD4DRD3XIAP
SCHEMBL7791991 0.92 GHSR (0.58) GHSRDRD2DRD4DRD3XIAP
SCHEMBL7796084 0.92 GHSR (0.67) GHSRXIAPF7F3F2
SCHEMBL7786058 0.91 GHSR (0.57) GHSRXIAPF7F3F2
SCHEMBL7791979 0.91 GHSR (0.76) GHSRDRD2DRD4DRD3XIAP
SCHEMBL7792151 0.91 GHSR (0.55) GHSRDRD2DRD4DRD3XIAP
SCHEMBL7791716 0.90 GHSR (0.66) GHSRDRD2DRD4DRD3XIAP
SCHEMBL8329860 0.90 GHSR (0.66) GHSRDRD2DRD4DRD3XIAP
SCHEMBL7786009 0.90 GHSR (0.54) GHSRDRD2DRD4DRD3XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659179-B1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO INC (US) 2001-11-21 EP claimed
US-5968924-A HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS MERCK & CO., INC. (US) 1999-10-19 US claimed
US-5968924-A HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS MERCK & CO., INC. (US) 1999-10-19 US disclosed